Physician profile
Meyer E Cohen
NPI 1912017591
$1,785.72
in general payments reported to CMS, 2019-2025
17 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.99 · 2021: $844 · 2022: $103 · 2023: $108 · 2024: $249 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $812.00 | 2021 | |
| Pfizer INC. | $184.78 | 2021-2025 | |
| Novo Nordisk INC | $153.00 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $120.26 | 2022-2025 | |
| Glaxosmithkline, LLC. | $96.24 | 2023-2025 | Arexvy, Shingrix |
| Abbvie INC. | $79.94 | 2024-2025 | |
| Astellas Pharma US INC | $50.28 | 2024-2025 | Veozah |
| Edwards Lifesciences Corporation | $47.80 | 2025 | |
| Amgen INC. | $40.53 | 2023-2025 | Repatha, Otezla, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.68 | 2021-2025 | Xifaxan |
| Medtronic Vascular, INC. | $32.39 | 2019 | |
| Nevro Corp. | $27.82 | 2024 | Senza |
| Boston Scientific Corporation | $26.67 | 2024 | Watchman Flx |
| Horizon Therapeutics Plc | $26.28 | 2022 | |
| Exact Sciences Corporation | $19.68 | 2025 | The Cologuard Plus Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $18.77 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $16.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meyer Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.